Jump to ContentJump to Main Navigation
India and the Patent WarsPharmaceuticals in the New Intellectual Property Regime$
Users without a subscription are not able to see the full content.

Murphy Halliburton

Print publication date: 2017

Print ISBN-13: 9781501713460

Published to Cornell Scholarship Online: September 2018

DOI: 10.7591/cornell/9781501713460.001.0001

Show Summary Details
Page of

PRINTED FROM Cornell University Press SCHOLARSHIP ONLINE (www.cornell.universitypressscholarship.com). (c) Copyright University of Cornell University Press, 2020. All Rights Reserved. An individual user may print out a PDF of a single chapter of a monograph in Cornell for personal use. date: 29 May 2020

The View from Hyderabad

The View from Hyderabad

The “Indian” Pharmaceutical Industry and the New Patent Regime

Chapter:
(p.116) 5 The View from Hyderabad
Source:
India and the Patent Wars
Author(s):

Murphy Halliburton

Publisher:
Cornell University Press
DOI:10.7591/cornell/9781501713460.003.0006

The boom town of Hyderabad is the center of India’s pharmaceutical industry, and this was where I met with representatives from two Indian pharmaceutical companies to discuss topics such as economies of scale in pharmaceutical production—the special capacity of the Indian pharma sector—licenses with foreign multinationals such as Gilead and prospects for new research and development. This chapter argues that those who anticipate a simple takeover by “multinational” companies of “Indian” companies, which are in fact also multinational, simplify what are complex and surprising emergences negotiated by quite powerful India-based corporate actors. The chapter also examines the first two patented drugs developed in India under the new patent regime, an anti-malarial medication and a cancer drug, and considers whether new research by Indian companies will focus on medical problems affecting low income countries or on products for high income markets.

Keywords:   Indian pharmaceutical companies, multinational companies, research and development, Active Pharmaceutical Ingredients, Ranbaxy

Cornell Scholarship Online requires a subscription or purchase to access the full text of books within the service. Public users can however freely search the site and view the abstracts and keywords for each book and chapter.

Please, subscribe or login to access full text content.

If you think you should have access to this title, please contact your librarian.

To troubleshoot, please check our FAQs, and if you can't find the answer there, please contact us.